BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, July 7, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: House passes H.R. 1, restoring R&D tax cuts
Breaking News: Self-amplifying mRNA technology underscored for next big pandemic
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Pfizer reports new class of muscarinic agonists
Aug. 30, 1996
CRM-1.13.1: Nicotinic agonist based on lobeline
Aug. 30, 1996
Memantine enters phase I for AIDS-related dementia, painful peripheral neuropathies
Aug. 30, 1996
Synapton phase III trials concluded
Aug. 30, 1996
Prednisone suppresses acute phase in AD patients
Aug. 30, 1996
Botulinum toxin effective in treating writer's cramp
Aug. 30, 1996
Botulinum toxin effective in reducing upper limb spasticity
Aug. 30, 1996
Roche files for approval of Tasmar
Aug. 30, 1996
Tegretol-XR launched in U.S.
Aug. 30, 1996
CGP-25454 tested in healthy volunteers
Aug. 30, 1996
Previous
1
2
…
2712
2713
2714
2715
2716
2717
2718
2719
2720
…
2751
2752
Next
RSS